XAB2
Gene Information
- Official Symbol: XAB2
- Official Name: XPA binding protein 2
- Aliases and Previous Symbols: N/A
- Entrez ID: 56949
- UniProt: Q9HCS7
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: N/A
- UniProt Summary: N/A
Pfam Domains GO Terms
Pfam Domains
No Pfam Domain information is available for this gene.
GO Terms
| generation of catalytic spliceosome for first transesterification step |
| spliceosomal conformational changes to generate catalytic conformation |
| post-mRNA release spliceosomal complex |
| Prp19 complex |
| U2-type catalytic step 2 spliceosome |
| transcription-coupled nucleotide-excision repair |
| catalytic step 2 spliceosome |
| blastocyst development |
| nucleotide-excision repair |
| cerebral cortex development |
| pallium development |
| ribonucleoprotein complex assembly |
| ribonucleoprotein complex subunit organization |
| telencephalon development |
| mRNA splicing, via spliceosome |
| RNA splicing, via transesterification reactions with bulged adenosine as nucleophile |
| RNA splicing, via transesterification reactions |
| in utero embryonic development |
| forebrain development |
| RNA splicing |
| ribonucleoprotein complex biogenesis |
| mRNA processing |
| DNA repair |
| chordate embryonic development |
| transcription, DNA-templated |
| nucleic acid-templated transcription |
| embryo development ending in birth or egg hatching |
| RNA biosynthetic process |
| mRNA metabolic process |
| brain development |
| DNA metabolic process |
| cellular response to DNA damage stimulus |
| head development |
| cellular protein-containing complex assembly |
| RNA processing |
| embryo development |
| central nervous system development |
| nucleobase-containing compound biosynthetic process |
| heterocycle biosynthetic process |
| aromatic compound biosynthetic process |
| organic cyclic compound biosynthetic process |
| protein-containing complex assembly |
| cellular nitrogen compound biosynthetic process |
| RNA metabolic process |
| cellular response to stress |
| cellular macromolecule biosynthetic process |
| macromolecule biosynthetic process |
| protein-containing complex subunit organization |
| membrane |
| gene expression |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
Most Correlated Genes in Chemogenomics
| Gene | Correlation |
|---|---|
| PRIM1 | 0.575 |
| UPF1 | 0.529 |
| EXOSC5 | 0.494 |
| PSMB4 | 0.491 |
| RPS12 | 0.488 |
| POLA1 | 0.488 |
| POLR2J3 | 0.484 |
| CBWD3 | 0.482 |
| C1QTNF9B | 0.479 |
| DDTL | 0.471 |
| PSMB2 | 0.469 |
| SUPT5H | 0.464 |
| TCEB3CL2 | 0.463 |
| KRT2 | 0.462 |
| COPG1 | 0.46 |
| FAM25B | 0.459 |
| CBWD5 | 0.456 |
| TBC1D3H | 0.455 |
| PSMC5 | 0.45 |
| CBWD6 | 0.447 |
| COPA | 0.446 |
| TBC1D3F | 0.446 |
| TFIP11 | 0.444 |
| PSMA6 | 0.442 |
| PSMD3 | 0.44 |
| TCEB3C | 0.439 |
| ATP6V0B | 0.438 |
| RRP7A | 0.438 |
| KRT78 | 0.438 |
| PSMA7 | 0.437 |
| ORC1 | 0.437 |
| EXOSC9 | 0.435 |
| AQR | 0.431 |
| CDC45 | 0.43 |
| SMG1 | 0.43 |
| ZNF830 | 0.428 |
| NUPL1 | 0.428 |
| TYMS | 0.428 |
| TCEB3CL | 0.426 |
| CHAF1A | 0.426 |
| RANBP2 | 0.425 |
| TBC1D3C | 0.425 |
| HIVEP3 | 0.425 |
| ALDH1B1 | 0.425 |
| INTS5 | 0.424 |
| PSMC2 | 0.423 |
| RBBP5 | 0.422 |
| ATP6V1A | 0.422 |
| TBC1D3G | 0.421 |
| CDH24 | 0.42 |
| TRAIP | 0.42 |
| CCNA2 | 0.419 |
| RPL35 | 0.418 |
| SF3A1 | 0.417 |
| ANKLE1 | 0.417 |
| WDR75 | 0.417 |
| SNRPA1 | 0.415 |
| TONSL | 0.415 |
| ISCU | 0.414 |
| C14orf93 | 0.412 |
| POLE | 0.411 |
| SYT9 | 0.411 |
| TBC1D3 | 0.411 |
| PLK1 | 0.411 |
| CCDC116 | 0.41 |
| COPE | 0.41 |
| SH3BP1 | 0.409 |
| NSF | 0.409 |
| CHD4 | 0.407 |
| PSMD14 | 0.406 |
| NUP160 | 0.406 |
| DNTTIP2 | 0.405 |
| AATF | 0.405 |
| OGFR | 0.404 |
| BYSL | 0.404 |
| TBC1D3I | 0.404 |
| TSPY2 | 0.404 |
| TPX2 | 0.404 |
| TBC1D3L | 0.404 |
| TBC1D3K | 0.404 |
| CACTIN | 0.404 |
| TBC1D3E | 0.404 |
| RPS5 | 0.403 |
| GOLGA8O | 0.403 |
| TRAPPC11 | 0.402 |
| COX7A2L | 0.402 |
| PRSS8 | 0.4 |
| MED17 | 0.4 |
| LRR1 | 0.4 |
| TP53TG3B | 0.4 |
| TP53TG3 | 0.4 |
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 739/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 1/1 |
| 909776.0 | 1/1 |
| bile duct | 28/28 |
| blood | 28/28 |
| bone | 26/26 |
| breast | 33/33 |
| central nervous system | 56/56 |
| cervix | 4/4 |
| colorectal | 17/17 |
| esophagus | 13/13 |
| fibroblast | 1/1 |
| gastric | 16/16 |
| kidney | 21/21 |
| liver | 20/20 |
| lung | 75/75 |
| lymphocyte | 16/16 |
| ovary | 26/26 |
| pancreas | 24/24 |
| peripheral nervous system | 16/16 |
| plasma cell | 15/15 |
| prostate | 1/1 |
| skin | 24/24 |
| soft tissue | 9/9 |
| thyroid | 2/2 |
| upper aerodigestive | 22/22 |
| urinary tract | 29/29 |
| uterus | 5/5 |
Essentiality in NALM6
- Essentiality Rank: 444
- Expression level (log2 read counts): 6.04
Expression Distribution
XAB2 Expression in NALM6 Cells: 6.04